148 related articles for article (PubMed ID: 35462410)
21. From Somatic Variants Toward Precision Oncology: An Investigation of Reporting Practice for Next-Generation Sequencing-Based Circulating Tumor DNA Analysis.
Peng R; Zhang R; Horan MP; Zhou L; Chai SY; Pillay N; Tay KH; Badrick T; Li J
Oncologist; 2020 Mar; 25(3):218-228. PubMed ID: 32162803
[TBL] [Abstract][Full Text] [Related]
22. External Quality Assessment on Molecular Tumor Profiling with Circulating Tumor DNA-Based Methodologies Routinely Used in Clinical Pathology within the COIN Consortium.
van der Leest P; Rozendal P; Hinrichs J; van Noesel CJM; Zwaenepoel K; Deiman B; Huijsmans CJJ; van Eijk R; Speel EJM; van Haastert RJ; Ligtenberg MJL; van Schaik RHN; Jansen MPHM; Dubbink HJ; de Leng WW; Leers MPG; Tamminga M; van den Broek D; van Kempen LC; Schuuring E
Clin Chem; 2024 May; 70(5):759-767. PubMed ID: 38484302
[TBL] [Abstract][Full Text] [Related]
23. Liquid biopsy-based circulating tumour (ct)DNA analysis of a spectrum of myeloid and lymphoid malignancies yields clinically actionable results.
Mata DA; Lee JK; Shanmugam V; Marcus CB; Schrock AB; Williams EA; Ritterhouse LL; Hickman RA; Janovitz T; Patel NR; Kroger BR; Ross JS; Mirza KM; Oxnard GR; Vergilio JA; Elvin JA; Benhamida JK; Decker B; Xu ML
Histopathology; 2024 Jun; 84(7):1224-1237. PubMed ID: 38422618
[TBL] [Abstract][Full Text] [Related]
24. Circulating cell-free DNA-based biomarkers for prognostication and disease monitoring in adrenocortical carcinoma.
Lippert J; Smith G; Appenzeller S; Landwehr LS; Prete A; Steinhauer S; Asia M; Urlaub H; Elhassan YS; Kircher S; Arlt W; Fassnacht M; Altieri B; Ronchi CL
Eur J Endocrinol; 2024 Mar; 190(3):234-247. PubMed ID: 38451242
[TBL] [Abstract][Full Text] [Related]
25. Clinical application of circulating tumor DNA in metastatic cancers.
Raei N; Safaralizadeh R; Latifi-Navid S
Expert Rev Mol Diagn; 2023; 23(12):1209-1220. PubMed ID: 37797209
[TBL] [Abstract][Full Text] [Related]
26. Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle.
De Mattos-Arruda L; Weigelt B; Cortes J; Won HH; Ng CKY; Nuciforo P; Bidard FC; Aura C; Saura C; Peg V; Piscuoglio S; Oliveira M; Smolders Y; Patel P; Norton L; Tabernero J; Berger MF; Seoane J; Reis-Filho JS
Ann Oncol; 2014 Sep; 25(9):1729-1735. PubMed ID: 25009010
[TBL] [Abstract][Full Text] [Related]
27. Analytical and clinical validation of an amplicon-based next generation sequencing assay for ultrasensitive detection of circulating tumor DNA.
Poh J; Ngeow KC; Pek M; Tan KH; Lim JS; Chen H; Ong CK; Lim JQ; Lim ST; Lim CM; Goh BC; Choudhury Y
PLoS One; 2022; 17(4):e0267389. PubMed ID: 35486650
[TBL] [Abstract][Full Text] [Related]
28. Utility of ctDNA to support patient selection for early phase clinical trials: the TARGET study.
Rothwell DG; Ayub M; Cook N; Thistlethwaite F; Carter L; Dean E; Smith N; Villa S; Dransfield J; Clipson A; White D; Nessa K; Ferdous S; Howell M; Gupta A; Kilerci B; Mohan S; Frese K; Gulati S; Miller C; Jordan A; Eaton H; Hickson N; O'Brien C; Graham D; Kelly C; Aruketty S; Metcalf R; Chiramel J; Tinsley N; Vickers AJ; Kurup R; Frost H; Stevenson J; Southam S; Landers D; Wallace A; Marais R; Hughes AM; Brady G; Dive C; Krebs MG
Nat Med; 2019 May; 25(5):738-743. PubMed ID: 31011204
[TBL] [Abstract][Full Text] [Related]
29. Repeat Next-Generation Sequencing Testing on Progression in Men With Metastatic Prostate Cancer Can Identify New Actionable Alterations.
Park JJ; Chu A; Li J; Ali A; McKay RR; Hwang C; Labriola MK; Jang A; Kilari D; Mo G; Ravindranathan D; Graham LS; Sokolova A; Tripathi A; Pilling A; Jindal T; Ravindra A; Cackowski FC; Sweeney PL; Thapa B; Amery TS; Heath EI; Garje R; Zakharia Y; Koshkin VS; Bilen MA; Schweizer MT; Barata PC; Dorff TB; Cieslik M; Alva AS; Armstrong AJ
JCO Precis Oncol; 2024 Apr; 8():e2300567. PubMed ID: 38579192
[TBL] [Abstract][Full Text] [Related]
30. Exploring the tumor genomic landscape of aggressive prostate cancer by whole-genome sequencing of tissue or liquid biopsies.
Weiss S; Lamy P; Rusan M; Nørgaard M; Ulhøi BP; Knudsen M; Kassentoft CG; Farajzadeh L; Jensen JB; Pedersen JS; Borre M; Sørensen KD
Int J Cancer; 2024 Jul; 155(2):298-313. PubMed ID: 38602058
[TBL] [Abstract][Full Text] [Related]
31. Sequencing paired tumor DNA and white blood cells improves circulating tumor DNA tracking and detects pathogenic germline variants in localized colon cancer.
Gimeno-Valiente F; Martín-Arana J; Tébar-Martínez R; Gambardella V; Martínez-Ciarpaglini C; García-Micó B; Martínez-Castedo B; Palomar B; García-Bartolomé M; Seguí V; Huerta M; Moro-Valdezate D; Pla-Martí V; Pérez-Santiago L; Roselló S; Roda D; Cervantes A; Tarazona N
ESMO Open; 2023 Dec; 8(6):102051. PubMed ID: 37951129
[TBL] [Abstract][Full Text] [Related]
32. Dynamic ctDNA Mutational Complexity in Patients with Melanoma Receiving Immunotherapy.
Fitzgerald S; Blenkiron C; Stephens R; Mathy JA; Somers-Edgar T; Rolfe G; Martin R; Jackson C; Eccles M; Robb T; Rodger E; Lawrence B; Guilford P; Lasham A; Print CG
Mol Diagn Ther; 2023 Jul; 27(4):537-550. PubMed ID: 37099071
[TBL] [Abstract][Full Text] [Related]
33. Clinical utility of plasma ctDNA sequencing in metastatic urothelial cancer.
Helal C; Pobel C; Bayle A; Vasseur D; Nicotra C; Blanc-Durand F; Naoun N; Bernard-Tessier A; Patrikidou A; Colomba E; Flippot R; Fuerea A; Auger N; Ngo Camus M; Besse B; Lacroix L; Rouleau E; Ponce S; Italiano A; Loriot Y
Eur J Cancer; 2023 Dec; 195():113368. PubMed ID: 37897866
[TBL] [Abstract][Full Text] [Related]
34. The landscape of actionable genomic alterations in lung adenocarcinomas in India.
Sharma R; Kamireddy AP; Hussaini SM; Chatterjee S; Hasan Q; Jain J
Front Genet; 2023; 14():1256756. PubMed ID: 38155717
[TBL] [Abstract][Full Text] [Related]
35. The Mutational Landscape of Gastrointestinal Malignancies as Reflected by Circulating Tumor DNA.
Riviere P; Fanta PT; Ikeda S; Baumgartner J; Heestand GM; Kurzrock R
Mol Cancer Ther; 2018 Jan; 17(1):297-305. PubMed ID: 29133621
[TBL] [Abstract][Full Text] [Related]
36. Targeted next-generation sequencing panel (GlioSeq) provides comprehensive genetic profiling of central nervous system tumors.
Nikiforova MN; Wald AI; Melan MA; Roy S; Zhong S; Hamilton RL; Lieberman FS; Drappatz J; Amankulor NM; Pollack IF; Nikiforov YE; Horbinski C
Neuro Oncol; 2016 Mar; 18(3):379-87. PubMed ID: 26681766
[TBL] [Abstract][Full Text] [Related]
37. Serial Profiling of Circulating Tumor DNA Identifies Dynamic Evolution of Clinically Actionable Genomic Alterations in High-Risk Neuroblastoma.
Bosse KR; Giudice AM; Lane MV; McIntyre B; Schürch PM; Pascual-Pasto G; Buongervino SN; Suresh S; Fitzsimmons A; Hyman A; Gemino-Borromeo M; Saggio J; Berko ER; Daniels AA; Stundon J; Friedrichsen M; Liu X; Margolis ML; Li MM; Tierno MB; Oxnard GR; Maris JM; Mossé YP
Cancer Discov; 2022 Dec; 12(12):2800-2819. PubMed ID: 36108156
[TBL] [Abstract][Full Text] [Related]
38. Circulating tumor DNA landscape and prognostic impact of acquired resistance to targeted therapies in cancer patients: a national center for precision medicine (PRISM) study.
Bayle A; Belcaid L; Palmieri LJ; Teysonneau D; Cousin S; Spalato-Ceruso M; Aldea M; Vasseur D; Alame M; Blouin L; Soubeyran I; Nicotra C; Ngocamus M; Hollebecque A; Loriot Y; Besse B; Lacroix L; Rouleau E; Barlesi F; Andre F; Italiano A
Mol Cancer; 2023 Nov; 22(1):176. PubMed ID: 37924050
[TBL] [Abstract][Full Text] [Related]
39. Clinical and biological determinants of circulating tumor DNA detection and prognostication using a next-generation sequencing panel assay.
Hsiehchen D; Espinoza M; Gerber DE; Beg MS
Cancer Biol Ther; 2021 Sep; 22(7-9):455-464. PubMed ID: 34392779
[TBL] [Abstract][Full Text] [Related]
40. The Molecular Tumor Board of the Regina Elena National Cancer Institute: from accrual to treatment in real-world.
Giacomini P; Valenti F; Allegretti M; Pallocca M; De Nicola F; Ciuffreda L; Fanciulli M; Scalera S; Buglioni S; Melucci E; Casini B; Carosi M; Pescarmona E; Giordani E; Sperati F; Jannitti N; Betti M; Maugeri-Saccà M; Cecere FL; Villani V; Pace A; Appetecchia M; Vici P; Savarese A; Krasniqi E; Ferraresi V; Russillo M; Fabi A; Landi L; Minuti G; Cappuzzo F; Zeuli M; Ciliberto G
J Transl Med; 2023 Oct; 21(1):725. PubMed ID: 37845764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
